Literature DB >> 9040743

Dystrophin expression in a Duchenne muscular dystrophy patient with a frame shift deletion.

T W Prior1, C Bartolo, A C Papp, P J Snyder, M S Sedra, A H Burghes, J T Kissel, M H Luquette, C Y Tsao, J R Mendell.   

Abstract

The exon 45 deletion is a common dystrophin gene deletion. Although this is an out-of-frame deletion, which should not allow for protein synthesis, it has been observed in mildly affected patients. We describe a patient with an exon 45 deletion who produced protein, but still had a severe Duchenne muscular dystrophy phenotype. RT-PCR analysis and cDNA sequencing from the muscle biopsy sample revealed that the exon 45 deletion induced exon skipping of exon 44, which resulted in an in-frame deletion and the production of dystrophin. A conformational change in dystrophin induced by the deletion is proposed as being responsible for the severe phenotype in the patient. We feel that the variable clinical phenotype observed in patients with the exon 45 deletion is not due to exon splicing but may be the result of other environmental or genetic factors, or both.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9040743     DOI: 10.1212/wnl.48.2.486

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Deletional mutations of dystrophin gene and carrier detection in eastern India.

Authors:  Jayasri Basak; Uma B Dasgupta; Subhash Chandra Mukherjee; Shyamal Kumar Das; Asit Kumar Senapati; Tapas Kumar Banerjee
Journal:  Indian J Pediatr       Date:  2009-11-12       Impact factor: 1.967

Review 2.  Experience and strategy for the molecular testing of Duchenne muscular dystrophy.

Authors:  Thomas W Prior; Scott J Bridgeman
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

Review 3.  Mechanisms of resistance to pathogenesis in muscular dystrophies.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

Review 4.  Normal and altered pre-mRNA processing in the DMD gene.

Authors:  Sylvie Tuffery-Giraud; Julie Miro; Michel Koenig; Mireille Claustres
Journal:  Hum Genet       Date:  2017-06-09       Impact factor: 4.132

5.  Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45.

Authors:  Andrew R Findlay; Nicolas Wein; Yuuki Kaminoh; Laura E Taylor; Diane M Dunn; Jerry R Mendell; Wendy M King; Alan Pestronk; Julaine M Florence; Katherine D Mathews; Richard S Finkel; Kathryn J Swoboda; Michael T Howard; John W Day; Craig McDonald; Aurélie Nicolas; Elisabeth Le Rumeur; Robert B Weiss; Kevin M Flanigan
Journal:  Ann Neurol       Date:  2015-03-02       Impact factor: 10.422

6.  Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation.

Authors:  Emanuela Gussoni; Richard R Bennett; Kristina R Muskiewicz; Todd Meyerrose; Jan A Nolta; Irene Gilgoff; James Stein; Yiu-Mo Chan; Hart G Lidov; Carsten G Bönnemann; Arpad Von Moers; Glenn E Morris; Johan T Den Dunnen; Jeffrey S Chamberlain; Louis M Kunkel; Kenneth Weinberg
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

7.  DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.

Authors:  Luca Bello; Lauren P Morgenroth; Heather Gordish-Dressman; Eric P Hoffman; Craig M McDonald; Sebahattin Cirak
Journal:  Neurology       Date:  2016-06-24       Impact factor: 9.910

8.  A novel splicing silencer generated by DMD exon 45 deletion junction could explain upstream exon 44 skipping that modifies dystrophinopathy.

Authors:  Ery Kus Dwianingsih; Rusdy Ghazali Malueka; Atsushi Nishida; Kyoko Itoh; Tomoko Lee; Mariko Yagi; Kazumoto Iijima; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2014-05-29       Impact factor: 3.172

9.  Identification of transcripts from a subtraction library which might be responsible for the mild phenotype in an intrafamilially variable course of Duchenne muscular dystrophy.

Authors:  Marco Sifringer; Birgit Uhlenberg; Stefanie Lammel; Rita Hanke; Benjamin Neumann; Arpad von Moers; Ina Koch; Astrid Speer
Journal:  Hum Genet       Date:  2003-11-05       Impact factor: 4.132

10.  Targeted exon skipping to address "leaky" mutations in the dystrophin gene.

Authors:  Sue Fletcher; Carl F Adkin; Penny Meloni; Brenda Wong; Francesco Muntoni; Ryszard Kole; Clayton Fragall; Kane Greer; Russell Johnsen; Steve D Wilton
Journal:  Mol Ther Nucleic Acids       Date:  2012-10-16       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.